165 related articles for article (PubMed ID: 32215268)
1. The Management of Patients Diagnosed with Incidental Prostate Cancer: Narrative Review.
Abedi AR; Ghiasy S; Fallah-Karkan M; Rahavian A; Allameh F
Res Rep Urol; 2020; 12():105-109. PubMed ID: 32215268
[TBL] [Abstract][Full Text] [Related]
2. Are transrectal prostate biopsies routinely indicated in patients with incidentally diagnosed prostate cancer following transurethral resection of the prostate for benign disease?
Lee LS; Thiruneelakandasivam S; Hong MK; Peters JS; Warren A; Mills R; Greenberg D; Wright K; Gnanapragasam V
Urol Int; 2013; 91(4):397-403. PubMed ID: 23921216
[TBL] [Abstract][Full Text] [Related]
3. [Prostate cancer development after transurethral resection of the prostate--histopathological studies of radical prostatectomy specimens].
Kanno H; Umemoto S; Izumi K; Hasumi H; Osada Y; Ohta J; Mikata K; Tuchiya F
Nihon Hinyokika Gakkai Zasshi; 2006 May; 97(4):649-59. PubMed ID: 16768146
[TBL] [Abstract][Full Text] [Related]
4. Outcome of radical prostatectomy for incidental carcinoma of the prostate.
Melchior S; Hadaschik B; Thüroff S; Thomas C; Gillitzer R; Thüroff J
BJU Int; 2009 Jun; 103(11):1478-81. PubMed ID: 19076134
[TBL] [Abstract][Full Text] [Related]
5. [Application value of diagnostic TURP for patients with serum PSA abnormality].
Yuan J; Zhao H; Wu B
Zhonghua Nan Ke Xue; 2013 Nov; 19(11):999-1002. PubMed ID: 24341094
[TBL] [Abstract][Full Text] [Related]
6. The impact of prior TURP on radical prostatectomy surgical margins: a multicenter analysis.
Gacci M; Simonato A; Lanciotti M; Ennas M; Varca V; Maffezzini M; Imbimbo C; Gontero P; Schiavina R; Carini M; Martorana G; Nicita G; Mirone V; Carmignani G
Urol Int; 2013; 91(1):62-8. PubMed ID: 23735440
[TBL] [Abstract][Full Text] [Related]
7. HoLEP provides a higher prostate cancer detection rate compared to bipolar TURP: a matched-pair analysis.
Rosenhammer B; Lausenmeyer EM; Mayr R; Burger M; Eichelberg C
World J Urol; 2018 Dec; 36(12):2035-2041. PubMed ID: 29858700
[TBL] [Abstract][Full Text] [Related]
8. Post-operative serial prostate-specific antigen and transrectal ultrasound for staging incidental carcinoma of the prostate.
Feneley MR; Webb JA; McLean A; Kirby RS
Br J Urol; 1995 Jan; 75(1):14-20. PubMed ID: 7531587
[TBL] [Abstract][Full Text] [Related]
9. Ductal adenocarcinoma of the prostate diagnosed on transurethral biopsy or resection is not always indicative of aggressive disease: implications for clinical management.
Aydin H; Zhang J; Samaratunga H; Tan N; Magi-Galluzzi C; Klein E; Jones JS; Zhou M
BJU Int; 2010 Feb; 105(4):476-80. PubMed ID: 19709071
[TBL] [Abstract][Full Text] [Related]
10. Incidental prostate cancer: a 10-year review of a tertiary center, Tehran, Iran.
Abedi AR; Fallah-Karkan M; Allameh F; Ranjbar A; Shadmehr A
Res Rep Urol; 2018; 10():1-6. PubMed ID: 29392121
[TBL] [Abstract][Full Text] [Related]
11. Interval from transurethral resection of prostate to laparoscopic radical prostatectomy does not affect outcomes for incidental prostate cancer.
Wang YY; Zheng XY; Mao QQ; Xie LP
Arch Med Sci; 2024; 20(1):133-137. PubMed ID: 38414460
[TBL] [Abstract][Full Text] [Related]
12. Probability of finding T1a and T1b (incidental) prostate cancer during TURP has decreased in the PSA era.
Jones JS; Follis HW; Johnson JR
Prostate Cancer Prostatic Dis; 2009; 12(1):57-60. PubMed ID: 18379587
[TBL] [Abstract][Full Text] [Related]
13. A review of radical prostatectomy from three centres in the UK: clinical presentation and outcome.
Feneley MR; Gillatt DA; Hehir M; Kirby RS
Br J Urol; 1996 Dec; 78(6):911-8; discussion 919-20. PubMed ID: 9014719
[TBL] [Abstract][Full Text] [Related]
14. Clinical and Histopathological Characteristics of Prostate Cancer Patients Taken to Palliative Transurethral Prostate Resection.
Rojas-Manrique JP; Ramírez Ramírez A; Becerra Méndez LM; Ramos Ulloa JG; Riveros C; Varela Ramirez R
Cureus; 2019 Sep; 11(9):e5740. PubMed ID: 31723501
[TBL] [Abstract][Full Text] [Related]
15. An Advanced but Traditional Technique of Transurethral Resection of the Prostate in Order not to Overlook Stage T1 Prostate Cancer.
Morita M; Matsuura T
Curr Urol; 2012 May; 6(1):21-6. PubMed ID: 24917705
[TBL] [Abstract][Full Text] [Related]
16. The Predictive Role of Prostate-Specific Antigen Changes Following Transurethral Resection of the Prostate for Patients with Localized Prostate Cancer.
Wu CT; Huang YC; Chen WC; Chen MF
Cancers (Basel); 2020 Dec; 13(1):. PubMed ID: 33383882
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance and predictors of oncologic outcome after radical prostatectomy for invisible prostate cancer on multiparametric MRI.
Chung DY; Koh DH; Goh HJ; Kim MS; Lee JS; Jang WS; Choi YD
BMC Cancer; 2018 Nov; 18(1):1057. PubMed ID: 30382916
[TBL] [Abstract][Full Text] [Related]
18. Population based study of predictors of adverse pathology among candidates for active surveillance with Gleason 6 prostate cancer.
Vellekoop A; Loeb S; Folkvaljon Y; Stattin P
J Urol; 2014 Feb; 191(2):350-7. PubMed ID: 24071481
[TBL] [Abstract][Full Text] [Related]
19. Radical prostatectomy for incidental (stage T1a-T1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence.
Capitanio U; Scattoni V; Freschi M; Briganti A; Salonia A; Gallina A; Colombo R; Karakiewicz PI; Rigatti P; Montorsi F
Eur Urol; 2008 Jul; 54(1):118-25. PubMed ID: 18314255
[TBL] [Abstract][Full Text] [Related]
20. Does transurethral resection of prostate (TURP) affect outcome in patients who subsequently develop prostate cancer?
D'Ambrosio DJ; Ruth K; Horwitz EM; Chen DY; Pollack A; Buyyounouski MK
Urology; 2008 May; 71(5):938-41. PubMed ID: 18279939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]